BioNTech SE (BNTX) Share-based Compensation (IS) (2021 - 2025)

BioNTech SE (BNTX) has 5 years of Share-based Compensation (IS) data on file, last reported at -$7.0 million in Q4 2025.

• In Q4 2025, Share-based Compensation (IS) rose 40.04% year-over-year to -$7.0 million; the TTM figure through Dec 2025 stood at -$28.7 million (up 83.04% YoY), while the FY2025 annual figure was -$28.6 million, up 82.69% from the prior year.
• Share-based Compensation (IS) slipped to -$7.0 million in Q4 2025, from -$4.9 million in the prior quarter.
• Across five years, Share-based Compensation (IS) topped out at -$1.7 million in Q3 2022 and bottomed at -$778.9 million in Q1 2023.
• A 5-year average of -$63.4 million and a median of -$5.4 million in 2023 frame the typical range for Share-based Compensation (IS).
• Annual changes were most pronounced in 2023 — Share-based Compensation (IS) tumbled 38456.63% — and 2024, when it jumped 99.67%.
• Year by year, Share-based Compensation (IS) stood at -$2.7 million in 2021, then plunged by 1650.25% to -$48.1 million in 2022, then jumped by 88.8% to -$5.4 million in 2023, then plunged by 116.51% to -$11.6 million in 2024, then surged by 40.04% to -$7.0 million in 2025.
• The last three Share-based Compensation (IS) figures came in at -$7.0 million (Q4 2025), -$4.9 million (Q3 2025), and -$13.0 million (Q2 2025), per Business Quant data.

Peer Comparison